The global angiography devices market accounted for USD 10894.9 Million in 2020 and is expected to reach USD 18233.2 Million by 2028, growing at a CAGR of 6.7% from 2021 to 2028.
The global angiography devices market accounted for USD 10894.9 Million in 2020 and is expected to reach USD 18233.2 Million by 2028, growing at a CAGR of 6.7% from 2021 to 2028.
Angiography devices are used to conduct angiography, a medical imaging technique that allows doctors to see into the body's blood vessels and organs, particularly the arteries, veins, and heart chambers. It is conducted by injecting a dye that can be seen by X-rays into arteries or veins and examined using X-rays. The developed results are called angiograms.
Rising prevalence of cardiovascular diseases and a corresponding need for accurate diagnostics and can be expected to positively drive the growth of this market. One of the recent trends involves the development of innovative technologies that require lower doses of X-rays while preserving the image quality. Key vendors are also offering integrated transesophageal echo (TEE) with live fluoro imaging in order to display them in one view instead of conducting them separately.
The Covid-19 pandemic has a negative impact on the angiography devices market, with cardiovascular operations being severely disrupted due to the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve medical resources for Covid-19 patients at the outset of the pandemic. Furthermore, increased costs of treating Covid-19 patients and PPE resulted in reduced capital expenditure on imaging devices such as angiography devices.
A rising demand for minimally invasive surgeries can boost the growth of this market, as angiograms conducted during the diagnosis phase give a detailed, clear, and accurate picture of the blood vessels in a patient's heart, obviating the need for costly invasive surgery. Surgeons are also opting for such procedures owing to the reduced risks and costs associated with it.
Moreover, factors such as the prevalence of cardiovascular problems, an ageing population, rising obesity rates due to lifestyle changes, and high consumption of fast food are likely to boost the global angiography devices market.
Angiography systems segment held a share of around 28% in 2020. Factors such as technological developments in angiography devices, an increase in the number of patients with cardiovascular diseases and other chronic ailments, and an increase in the number of angiography procedures performed around the world are all contributing to the huge share.
MRI segment will grow at a CAGR of over 5.8% from 2021 to 2028. Owing to its advantage of less radiation exposure in the diagnosis of heart disease, MRI is predicted to be the fastest-growing technology. MRI can gather pictures in any anatomical plane with good soft tissue contrast in three dimensions.
The North American region held a share of 31% in 2020. This is attributable to the presence of top companies such as GE Healthcare, Boston Scientific Corporation and Cordis Corporation among others. Moreover, the high rate of minimally invasive procedures adoption, easy reimbursements, growing geriatric population, and high medical equipment replacement rates are expected to generate huge demand for the market in this region.
The European region is projected to grow at a CAGR of around 6.2% over the forecast period. Increasing awareness of minimally invasive procedures, government investments, high prevalence of cardiovascular diseases are some of the factors causing the growth of the market in this region.
Some of key players in automated sortation system market are GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Canon Corporation, Shimadzu Corporation, Boston Scientific Corporation, Cordis Corporation, Medtronic Inc., AngioDynamics and Abbott Laboratories, among others.
Top companies are investing in research and development to offer an innovative product portfolio. Shimadzu Corporation, for example, produced three variants of Trinias and a minimally invasive Bi-plane angiography system in 2018. Medtronic Inc. also added the DxTerity Diagnostic Angiography Catheter line to their current catheter line in 2017.
By Product
By Technology
By Procedure
By Application
By Region
FrequentlyAsked Questions
The global angiography devices market was valued at USD 10894.9 Million in 2020.
The global angiography devices market is expected to reach USD 18233.2 Million by 2028, growing at a CAGR of 6.7% between 2021 to 2028.
Some of the key factors driving the global angiography devices market growth rising prevalence of cardiovascular diseases and need for accurate, minimally invasive diagnostics.
North America region held a substantial share of the angiography devices market in 2020. This is attributable to the presence of major players such GE Healthcare, Boston Scientific Corporation and Cordis Corporation, among others. European region is projected to grow at a significant rate owing to the rising demand for angiographic devices in the region.
Some of the major companies operating in the angiography devices market are GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Canon Corporation, Shimadzu Corporation, Boston Scientific Corporation, Cordis Corporation, Medtronic Inc., AngioDynamics and Abbott Laboratories among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed